Zhengye Biotechnology Says It Received Nasdaq Letter Confirming Regained Compliance With $1.00 Minimum Bid Price Requirement
Share
Why It Matters
Zhengye Biotechnology fixed a problem where its stock price had fallen too low for Nasdaq rules. Now that it's back in good standing, the company can stay listed on the big stock exchange.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.